Search Results - "Carpani, Rossana"

Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction by Valenti, Luca, Tripodi, Armando, La Mura, Vincenzo, Pelusi, Serena, Bianco, Cristiana, Scalambrino, Erica, Margarita, Sara, Malvestiti, Francesco, Ronzoni, Luisa, Clerici, Marigrazia, D’Ambrosio, Roberta, Fraquelli, Mirella, Carpani, Rossana, Prati, Daniele, Peyvandi, Flora

“…Background & AimsThe aim of this study was to examine the determinants of the interplay between liver damage and the coagulation balance in individuals at risk…”
Get full text

Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD by Pelusi, Serena, Ronzoni, Luisa, Rondena, Jessica, Rosso, Chiara, Pennisi, Grazia, Dongiovanni, Paola, Margarita, Sara, Carpani, Rossana, Soardo, Giorgio, Prati, Daniele, Cespiati, Annalisa, Petta, Salvatore, Bugianesi, Elisabetta, Valenti, Luca

“…Metabolic dysfunction associated steatotic liver disease (MASLD) has a strong genetic component. The aim of this study was to examine noninvasively the…”
Get full text

SAT-422 - Abdominal adiposity and insulin resistance are the main predictors of CAP values in individuals with metabolic dysfunction: the liver-bible cohort by Bianco, Cristiana, Pelusi, Serena, Margarita, Sara, Malvestiti, Francesco, Periti, Giulia, Rondena, Jessica, Tomasi, Melissa, Carpani, Rossana, Vidali, Matteo, Ceriotti, Ferruccio, Prati, Daniele, Valenti, Luca

Get full text

Abdominal adiposity and insulin resistance are the main predictors of CAP values in individuals with metabolic dysfunction: the liver-bible cohort by Bianco, Cristiana, Pelusi, Serena, Margarita, Sara, Malvestiti, Francesco, Periti, Giulia, Rondena, Jessica, Tomasi, Melissa, Carpani, Rossana, Vidali, Matteo, Ceriotti, Ferruccio, Prati, Daniele, Valenti, Luca

Get full text

Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women by Cherubini, Alessandro, Ostadreza, Mahnoosh, Jamialahmadi, Oveis, Pelusi, Serena, Rrapaj, Eniada, Casirati, Elia, Passignani, Giulia, Norouziesfahani, Marjan, Sinopoli, Elena, Baselli, Guido, Meda, Clara, Dongiovanni, Paola, Dondossola, Daniele, Youngson, Neil, Tourna, Aikaterini, Chokshi, Shilpa, Bugianesi, Elisabetta, Della Torre, Sara, Prati, Daniele, Romeo, Stefano, Valenti, Luca

“…Fatty liver disease (FLD) caused by metabolic dysfunction is the leading cause of liver disease and the prevalence is rising, especially in women. Although…”
Get full text

Independent determinants of CAP values in healthy individuals with dysmetabolism by Bianco, Cristiana, Pelusi, Serena, Grigoli, Eleonora Giacopuzzi, Santoro, Luigi, Malvestiti, Francesco, Tomasi, Melissa, Marini, Ilaria, Margarita, Sara, Carpani, Rossana, Prati, Daniele, Valenti, Luca

Get full text

Author Correction: Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women by Cherubini, Alessandro, Ostadreza, Mahnoosh, Jamialahmadi, Oveis, Pelusi, Serena, Rrapaj, Eniada, Casirati, Elia, Passignani, Giulia, Norouziesfahani, Marjan, Sinopoli, Elena, Baselli, Guido, Meda, Clara, Dongiovanni, Paola, Dondossola, Daniele, Youngson, Neil, Tourna, Aikaterini, Chokshi, Shilpa, Bugianesi, Elisabetta, Della Torre, Sara, Prati, Daniele, Romeo, Stefano, Valenti, Luca

Get full text

Predictors of controlled attenuation parameter in metabolic dysfunction by Bianco, Cristiana, Pelusi, Serena, Margarita, Sara, Tavaglione, Federica, Jamialahmadi, Oveis, Malvestiti, Francesco, Periti, Giulia, Rondena, Jessica, Tomasi, Melissa, Carpani, Rossana, Ronzoni, Luisa, Vidali, Matteo, Ceriotti, Ferruccio, Fraquelli, Mirella, Vespasiani‐Gentilucci, Umberto, Romeo, Stefano, Prati, Daniele, Valenti, Luca

“…Background & Aims Hepatic fat content can be non‐invasively estimated by controlled attenuation parameter (CAP) during transient elastography. The aim of this…”
Get full text